Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Research-grade specs Components: GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) + KPV (10 mg) Total strength: 80 mg per vial Format: Lyophilized powder, single-vial blend Pathways studied: Matrix remodelling (GHK-Cu), cell migration (BPC-157, TB-500), cytokine signalling (KPV) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Receptor and cytokine pathway interaction research Copper-peptide and tripeptide comparative research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
With a 3.0 mL mix (1.67 mg/mL), you would draw approximately 18 units (0.18 mL)
Influences of miR-320a on Proliferation and Apoptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis Through Targeting MAPK-Erk1/2
Some practitioners theorize that local abdominal injection may enhance regional fat mobilization, though this has not been conclusively proven in research
US$ 23.86
US$ 25.73
US$ 21.38
US$ 23.56
US$ 29.94
US$ 21.61
US$ 29.63
